HIV/AIDS

Ibalizumab Active in Multidrug Resistant HIV-1 Infection

Ibalizumab Active in Multidrug Resistant HIV-1 Infection

Lower degree of susceptibility to ibalizumab for 9 of 10 patients with virology failure, rebound.

Intervention Cuts Risk for HIV in Young Transgender Women

Intervention Cuts Risk for HIV in Young Transgender Women

Intervention group had greater reduction in condomless sex acts vs standard of care group.

International Antiviral Society-USA Updates Recommendations for HIV Treatment and Prevention

International Antiviral Society-USA Updates Recommendations for HIV Treatment and Prevention

The International Antiviral Society-USA Panel has updated its recommendations for the management and prevention of HIV infection, to reflect the most current data on new treatment regimens and strategies.

Low Rates of Syphilis Testing in High-Risk Men Who Are HIV Positive

Low Rates of Syphilis Testing in High-Risk Men Who Are HIV Positive

Close to one-third of sexually active HIV-positive men who have sex with men (MSM) have not received syphilis screening in the past 12 months.

HIV, Syphilis Screening Low With ED-Diagnosed PID in Adolescents

HIV, Syphilis Screening Low With ED-Diagnosed PID in Adolescents

Findings among teens diagnosed with pelvic inflammatory disease in the emergency department.

Guidelines for ART Updated for Those With or at Risk for HIV

Guidelines for ART Updated for Those With or at Risk for HIV

ART recommended for almost all HIV-infected; should be initiated as soon as possible post diagnosis.

Successful Screening and Referral for HIV, Hepatitis C in a Trauma Population

Successful Screening and Referral for HIV, Hepatitis C in a Trauma Population

Investigators added hepatitis C virus and HIV screening tests to standard trauma activation laboratory orders.

HPV Vaccine Failure Rates May Be Higher in Women, Girls With HIV

HPV Vaccine Failure Rates May Be Higher in Women, Girls With HIV

By

Vaccinated women and girls living with HIV may be at greater risk for HPV vaccine failure compared with women and girls without HIV.

Single High-Dose Liposomal Amphotericin B Effectively Treats HIV-Associated Cryptococcal Meningitis

Single High-Dose Liposomal Amphotericin B Effectively Treats HIV-Associated Cryptococcal Meningitis

Single high-dose liposomal amphotericin B (L-AmB) is non-inferior to daily dosed L-AmB at the standard dose in treatment of fungal clearance in HIV-associated cryptococcal meningitis.

Diabetes Risk Associated With Cirrhosis, Not Chronic HCV Infection, in HIV Positive Patients

Diabetes Risk Associated With Cirrhosis, Not Chronic HCV Infection, in HIV Positive Patients

Cirrhosis is associated with an increased risk for diabetes mellitus among patients living with HIV.

Efavirenz Does Not Increase Depression, Suicidal Ideation in HIV-Infected

Efavirenz Does Not Increase Depression, Suicidal Ideation in HIV-Infected

No increased risk of depression or suicidal ideation among persons living with HIV in Uganda.

National HIV Testing Day Is on June 27

National HIV Testing Day Is on June 27

Annual occasion is a good time for health care providers to encourage testing

FDA: Possible Risk of Neural Tube Birth Defects With Certain HIV Meds

FDA: Possible Risk of Neural Tube Birth Defects With Certain HIV Meds

By

The Agency has received reports of serious neural tube birth defects involving the brain, spine, and spinal cord in babies born to women who received dolutegravir for HIV treatment.

FDA approves antiretroviral therapy for multidrug-resistant HIV

FDA approves antiretroviral therapy for multidrug-resistant HIV

By

The FDA has approved Trogarzo for heavily treated adult patients living with HIV and whose HIV infections cannot be successfully treated with other currently available therapies.

CVS unintentionally reveals HIV status of 6,000 customers, per lawsuit

CVS unintentionally reveals HIV status of 6,000 customers, per lawsuit

By

CVS Health faces lawsuit for revealing the HIV status of 6,000 patients in Ohio.

Fatigue, muscle aches more common in women with HIV than men

Fatigue, muscle aches more common in women with HIV than men

The two most prevalent HIV symptoms, fatigue and muscle aches, are more common in women than men and can worsen with menopause.

Daily dose of PrEP raises coverage, protective drug concentrations

Daily dose of PrEP raises coverage, protective drug concentrations

Recommendations for daily doses of emtricitabine (FTC)/tenofovir disoproxil fumarate (TDF) resulted in protective drug concentrations for men and transgender women.

FDA OKs new medication for individuals with resistant HIV

FDA OKs new medication for individuals with resistant HIV

A new antiretroviral HIV treatment, Trogarzo (ibalizumab-uiyk), has been approved by the FDA for patients with HIV who have not have success with past HIV medications.

Newer HIV testing options underused in Black MSM and transgender women

Newer HIV testing options underused in Black MSM and transgender women

By

Increasing awareness of and access to newer HIV testing options such as free or reduced price on home and self-tests and couples HIV testing and counseling can facilitate increased levels of consistent testing among young, Black MSM, and transgender women.

Bacterial vaginosis may alter links between contraception, HIV acquisition

Bacterial vaginosis may alter links between contraception, HIV acquisition

Bacterial vaginosis may cause an increased risk for HIV acquisition in women taking oral or injectable hormonal contraception.

Alcohol usage not linked to lower short-term CD4 cell count in HIV

Alcohol usage not linked to lower short-term CD4 cell count in HIV

Excessive alcohol consumption does not impact the decline of CD4 cell count in patients with HIV who have not undergone antiretroviral treatments.

HIV care worsened with chronicity of depression

HIV care worsened with chronicity of depression

Chronicity of depression is associated with increased likelihood of failure along the continuum of HIV care.

HIV screening at 25 years optimal for outcomes, cost

HIV screening at 25 years optimal for outcomes, cost

For young adults without known risk factors, a one-time routine HIV screen at 25 years would optimize clinical outcomes and be cost-effective.

Over one-third of U.S. HIV patients are not vaccinated against hepatitis B

One third of HIV patients in the United States remain unvaccinated against hepatitis B.

Combination ART may prevent progressive brain injury in HIV patients

Combination ART may prevent progressive brain injury in HIV patients

Post-seroconversion brain morphology can occur in HIV patients, but aviremia maintenance via cART can slow of prevent brain injuries.

HIV infection to diagnosis time decreasing

HIV infection to diagnosis time decreasing

By

A new report from the CDC finds that HIV is being diagnosed sooner after initial infection than in previous years.

Nivolumab treatment for lung cancer may successfully deplete HIV reservoirs

Nivolumab treatment for lung cancer may successfully deplete HIV reservoirs

Nivolumab treatment for non-small-cell lung cancer may induce successful depletion of HIV reservoir.

HIV occurrences decline in Uganda from 1999 to 2016

HIV occurrences decline in Uganda from 1999 to 2016

The decrease in HIV incidence in Uganda was facilitated by antiretroviral therapy, male circumcision, and adolescent abstinence.

Characteristics in transgender individuals may lead to more HIV tests

Characteristics in transgender individuals may lead to more HIV tests

More tests might be administered to transgender individuals who are female, black, or sex workers.

Dual HIV treatment provides simple, safe salvage regimen

Dual HIV treatment provides simple, safe salvage regimen

The dual combination of dolutegravir plus darunavir/ritonavir provided a simple and safe salvage therapy to suppress viral replication without metabolic impact in patients infected with HIV-1.

Sign Up for Free e-newsletters